ProHealth health Resource
 SUBSCRIBE TO OUR FREE E-NEWSLETTERS  
Click Here to Preview
Log In
Catalog Quick Order
Your Account
Shopping Cart
 Check Out
ProHealth: News, Research, Vitamins & Supplements About ProHealth ProHealth ImmuneSupport.com ProHealth Online Vitamin & Supplement Store ProHealth Treatment & Research Library ProHealth Community ProHealth Vitamins & Supplements Catalog
Your Purchase Helps Fund Health Research
Explore Our Health Sites
ProHealth Vitamin and Supplement Catalog
Your resource for specialty nutritional supplements, books, DVDs, resources for better living, health news & more!
ProHealth Health & Wellness Research & News Catalog
Your Purchases Help Fund Ongoing Research
 
 
Search our extensive library for information, solutions & support
Site
Message Board  
Abstracts
Newsletters  
Articles
Products  

Rheumatoid Arthritis Patients with HMO Coverage May Not Have Access to New Medications

November 6, 2002

Health maintenance organizations strive to lower the cost of rheumatoid arthritis care by reducing the use of new medications, not by lowering the number of hospital admissions or surgeries, according to research recently presented at the American College of Rheumatology Annual Scientific Meeting in New Orleans, Louisiana.

Most of the studies on the impact of health maintenance organizations (HMOs) and access to quality care have been conducted on healthy populations. These studies indicate that HMOs save costs by lowering the use of hospital stays. However, studies of the impact of HMOs on people with rheumatoid arthritis do not find that HMOs lower health care use, including hospital admissions, total joint replacement surgeries or outpatient surgeries.

In a study of 493 individuals, researchers analyzed whether people with rheumatoid arthritis receiving care from HMOs are less likely to use anti-TNF agents (etanercept or infliximab) or COX-2 inhibitors to treat their disease. The research shows that people with rheumatoid arthritis who participate in HMOs were significantly less likely to receive any form of anti-TNF therapy or COX-2 inhibitors.

"In recent years, several expensive new medications have been approved by the U.S. Food and Drug Administration for the care of individuals with rheumatoid arthritis. This study indicates that rheumatoid arthritis patients in HMOs are much less likely to receive these new medications." said Edward Yelin, PhD, Professor of Medicine and Health Policy, University of California-San Francisco, and a lead investigator in the study.

"Since we had previously found that HMOs do not reduce the use of the hospital or surgery for such patients, controlling medications may be the way that they seek to reduce the costs of treating people with this disease."

The American College of Rheumatology is the professional organization for rheumatologists and health professionals who share a dedication to healing, preventing disability and curing arthritis and related rheumatic and musculoskeletal diseases. For more information on the ACR's annual meeting, see www.rheumatology.org.




DISCUSS THIS ARTICLE   (0 existing comments) Post a Comment 
health Research Articles



[ Be the first to comment on this article ]




Rheumatoid Arthritis Patients with HMO Coverage May Not Have Access to New Medications Article Tools
Print Page Print Page Email Article Email Article
Discuss Discuss
  Rate This
Most Viewed Articles & Abstracts
Chocolate's Potential Health Benefits – and its Effect on Chronic Fatigue Syndrome Patients [more]

USDA Food Guide Pyramid [more]

Friday, Dec 5: Live Chat with ME/CFS Research Expert Suzanne Vernon, PhD – “Working to Translate Sci... [more]

Vitamin D Experts' “Call to Action” Urges Major RDA Increase to 2000 IU [more]

Vitamin D and mood disorders among women: An integrative review - Source: Journal of Midwifery and W... [more]

Featured Vitamins, Supplements, and Health Products
Daily Health ProPack™ Daily Health ProPack™
Super Multiple II - 46 essential nutrients
Cranberry Cranberry
All the benefits of cranberry without the calories
Vitamin D3 5000™ Vitamin D3 5000™
High potency for maximum support of bones
Austin HealthMate HEPA Austin HealthMate HEPA
Double filtration system removes 99.9% of all particles in up to 1,500 sq' of air
Cuddle Ewe™ Sleep Soundly Set - Twin Cuddle Ewe™ Sleep Soundly Set - Twin
Price includes a $21 domestic shipping charge
Security Enabled AlertSite is a leading provider of Web site monitoring and performance management solutions that help businesses ensure optimum Web experiences for their customers. TrustE Better Business Bureau BizRate Customer Certified (GOLD) Site
ProHealth Vitamin and Supplement SmartSavings Club

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
ADVANCED MEDICAL LABS   |   WHOLESALE   |   AFFILIATES   |   CONTACT US   |   PRIVACY   |   GLOSSARY   |   CUSTOMER SERVICE   |   RELATED SITES   |   RSS
Email us or Call toll-free 800-366-6056 · Monday through Friday, 7 a.m.-5 p.m. Pacific Time
International Callers dial 001.805.564.3064
Copyright © 2009 ProHealth, Inc.